Cresco Labs Stock Current Ratio
| CRLBF Stock | USD 0.92 0.02 2.13% |
Cresco Labs fundamentals help investors to digest information that contributes to Cresco Labs' financial success or failures. It also enables traders to predict the movement of Cresco OTC Stock. The fundamental analysis module provides a way to measure Cresco Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cresco Labs otc stock.
Cresco |
Cresco Labs OTC Stock Current Ratio Analysis
Cresco Labs' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Cresco Labs Current Ratio | 1.31 X |
Most of Cresco Labs' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cresco Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Cresco Labs has a Current Ratio of 1.31 times. This is 54.98% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current ratio for all United States stocks is 39.35% higher than that of the company.
Cresco Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cresco Labs' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cresco Labs could also be used in its relative valuation, which is a method of valuing Cresco Labs by comparing valuation metrics of similar companies.Cresco Labs is currently under evaluation in current ratio category among its peers.
Cresco Fundamentals
| Return On Equity | -0.0635 | |||
| Return On Asset | 0.0399 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 1.29 B | |||
| Shares Outstanding | 280.99 M | |||
| Shares Owned By Insiders | 22.87 % | |||
| Shares Owned By Institutions | 7.22 % | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 0.83 X | |||
| Revenue | 821.68 M | |||
| Gross Profit | 429.79 M | |||
| EBITDA | (159.63 M) | |||
| Net Income | (319.6 M) | |||
| Cash And Equivalents | 130.04 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 465.08 M | |||
| Debt To Equity | 0.88 % | |||
| Current Ratio | 1.31 X | |||
| Book Value Per Share | 2.62 X | |||
| Cash Flow From Operations | 14.49 M | |||
| Earnings Per Share | (1.15) X | |||
| Target Price | 7.04 | |||
| Number Of Employees | 3.3 K | |||
| Beta | 2.25 | |||
| Market Capitalization | 545.97 M | |||
| Total Asset | 1.78 B | |||
| Z Score | 0.6 | |||
| Net Asset | 1.78 B |
About Cresco Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cresco Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cresco Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cresco Labs based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Cresco OTC Stock
Cresco Labs financial ratios help investors to determine whether Cresco OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cresco with respect to the benefits of owning Cresco Labs security.